...
首页> 外文期刊>The Indian journal of medical research. >Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario
【24h】

Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario

机译:印度部族人口中的6-磷酸葡萄糖脱氢酶(G6PD)缺乏症-国家情况

获取原文
获取原文并翻译 | 示例

摘要

It is believed that the tribal people, who constitute 8.6 per cent of the total population (2011 census of India), are the original inhabitants of India. Glucose-6-phosphate-dehydrogenase (G6PD) deficiency is an X-linked genetic defect, affecting around 400 million people worldwide and is characterized by considerable biochemical and molecular heterogeneity. Deficiency of this enzyme is highly polymorphic in those areas where malaria is/has been endemic. G6PD deficiency was reported from India more than 50 years ago. t0 he prevalence varies from 2.3 to 27.0 per cent with an overall prevalence of 7.7 per cent in different tribal groups. Since the tribal populations live in remote areas where malaria is/has been endemic, irrational use of antimalarial drugs could result in an increased number of cases with drug induced haemolysis. Therefore, before giving antimalarial therapy, routine screening for G6PD deficiency should be undertaken in those tribal communities where its prevalence is high.
机译:据认为,部落人口占印度总人口的8.6%(2011年印度人口普查),是印度的原始居民。 6-磷酸葡萄糖脱氢酶(G6PD)缺乏症是X连锁遗传缺陷,影响全球约4亿人,其生化和分子异质性很高。在疟疾流行地区,这种酶的缺乏是高度多态的。 G6PD缺乏症是在50多年前从印度报道的。患病率从2.3%到27.0%不等,不同部落群体的患病率总体为7.7%。由于部族人口居住在疟疾流行的偏远地区,因此不合理使用抗疟疾药物可能导致药物引起的溶血病例增加。因此,在进行抗疟疾治疗之前,应在那些普遍存在G6PD缺陷的部落社区进行常规筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号